The utility of biomarker risk prediction score in patients with chronic heart failure.

Alexander E BerezinAlexander A KremzerYulia V MartovitskayaTatyana A BerezinaTatyana A Samura

Published in: Clinical hypertension (2016)

Biomarker risk score for cumulative cardiovascular events, constructed by measurement of circulating NT-pro-BNP, galectin-3, hs-CRP, osteoprotegerin, CD31+/annexin V+ EMPs and CD31(+)/annexin V(+) EMPs to CD14(+)CD309(+) MPCs ratio, allowing reliably predict the probability survival of patients with CHF.

Keyphrases

cardiovascular events
coronary artery disease
cardiovascular disease
wastewater treatment
nk cells
nuclear factor
ejection fraction
type diabetes
free survival
anti inflammatory